Skip to main content
. 2018 Jul 22;2018:7464320. doi: 10.1155/2018/7464320

Table 5.

Continuous glucose-monitoring findings of subjects with and without macrovascular disease.

Variable No macrovascular disease (n = 49) Macrovascular disease (n = 72) p value
Highest value (mmol/L) 13.4 (11.3–15.85) 13.0 (11.3–15) 0.35
Lowest value (mmol/L) 4.4 (3.2–5.25) 3.7 (2.8–5) 0.09
Mean blood glucose (mmol/L) 7.6 (6.85–9.0) 7.3 (6.6–8.4) 0.3
Standard deviation (mmol/L) 3.0 (1.3–2.3) 1.8 (1.5–2.4) 0.9
Number of high excursions 8 (6–10) 8 (5–10) 0.49
Number of low excursions 0 (0–2) 1 (0–2) 0.10
AUC above 7.8 mmol/L 0.64 (0.24–1.76) 0.57 (0.21–1.35) 0.39
AUC below 3.9 mmol/L 0 (0–0.01) 0 (0–0.03) 0.05
Duration during 72 hr period with BG above 7.8 mmol/L (%) 37 (18.5–66.5) 35 (20–58) 0.39
Duration during 72 hr period with BG within 3.9–7.8 mmol/L (%) 58 (31.5–79) 60 (41–77) 0.63
Duration during 72 hr period with BG below 3.9 mmol/L (%) 0 (0-1) 1 (0–5) 0.02

Values are expressed as number (%) of patients or median (IQR). AUC: area under curve.